Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China National Accord Medicines's quarterly market cap
increased
from Dec. 2025 (¥13,669 Mil) to Mar. 2026 (¥14,379 Mil) but then
declined
from Mar. 2026 (¥14,379 Mil) to Jun. 2026 (¥11,577 Mil).
China National Accord Medicines's annual market cap
increased
from Dec. 2023 (¥16,135 Mil) to Dec. 2024 (¥16,280 Mil) but then
declined
from Dec. 2024 (¥16,280 Mil) to Dec. 2025 (¥13,669 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. China National Accord Medicines's Enterprise Value for Today is ¥11,819 Mil.
China National Accord Medicines (SZSE:000028) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
China National Accord Medicines Market Cap Related Terms
China National Accord Medicines Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:000028 vs MCK, COR, CAH: Market Cap Comparison
For the Medical Distribution subindustry, China National Accord Medicines's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China National Accord Medicines Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Market Cap distribution charts can be found below:
* The bar in red indicates where China National Accord Medicines's Market Cap falls into.
China National Accord Medicines Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China National Accord Medicines (SZSE:000028) has a Market Cap of ¥11,370 Mil as of Sep. 15, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on China National Accord Medicines and its competitors. According to the industry distribution chart, China National Accord Medicines ranks #23 out of 126 companies in the Medical Distribution industry, placing it in the top 18.3%.
Is China National Accord Medicines' Market Cap too high?
China National Accord Medicines' current Market Cap is ¥11,370 Mil. Based on the distribution chart, China National Accord Medicines ranks #23 out of 126 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, China National Accord Medicines has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does China National Accord Medicines' Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, China National Accord Medicines ranks #23 out of 126 companies for Market Cap. This places China National Accord Medicines in the top 18% of its industry — outperforming the majority of peers. The industry median Market Cap is 143.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 143.55, based on 126 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on China National Accord Medicines and its competitors. For the Medical Distribution industry, the median Market Cap is 143.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China National Accord Medicines's current Market Cap is ¥11,370 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Accord Medicines stock overvalued right now?
China National Accord Medicines (SZSE:000028) has a current Market Cap of ¥11,370 Mil. The current Market Cap is ¥11,370 Mil. China National Accord Medicines' overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For China National Accord Medicines (SZSE:000028), the current Market Cap is ¥11,370 Mil as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
57GF Score
Get the complete analysis for SZSE:000028
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000028 has been successfully added to your 
